Byooviz 10 mg/ml solution for injection
SB11-2002
Phase 2 small_molecule active
Quick answer
Byooviz 10 mg/ml solution for injection for Neovascular Age-Related Macular Degeneration (AMD), Macular Oedema Secondary to Retinal Vein Occlusion (RVO), Myopic Choroidal Neovascularization (mCNV) is a Phase 2 program (small_molecule) at Samsung Bioepis NL B.V. with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Samsung Bioepis NL B.V.
- Indication
- Neovascular Age-Related Macular Degeneration (AMD), Macular Oedema Secondary to Retinal Vein Occlusion (RVO), Myopic Choroidal Neovascularization (mCNV)
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active